Pavo, Noemi <br/><br/>
The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients.  [electronic resource] 

 -  Scientific reports  02 2019 
 - 2554 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-019-38867-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers--blood<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Myelodysplastic-Myeloproliferative Diseases--diagnosis<br/>Neoplasms--diagnosis<br/>Neprilysin--blood<br/>Prognosis<br/>Survival Analysis